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Bacteria in nature are “plagued“ by various unpredictable environmental stresses, being population diversity one of the 
strategies adopted to survive. Phenotypic switching is one of the evolution processes that causes commutation between 
phenotypic states. This phenomenon shows up as variation in colony morphology. Alterations in colony morphotype traits 
may reveal altered cellular basis phenotype which can confer ensured virulence, antimicrobial resistance and persistence. 
However, the specific correlation between those traits and the biological impact is unknown. Phenotypic switching also 
occurs during biofilm formation, in that, bacteria have to adapt to this mode of growth expressing different phenotype 
traits often distinct from those expressed during planktonic growth. Often, after severe stresses, it is observed the survival 
of a small non-growing population, the persisters cells. The persister-state is fully reversible under growth stimulating 
conditions and therefore does not depend on genetic alterations. Bacterial persistence has been pointed out as switching 
between growing and dormant cells. Nevertheless, not only the responsive switching to environmental changes is 
important for survival of bacteria. Inherent heterogeneity may also be of major importance in environmental adaptation 
and persistence. Control of stress-response gene expression determines whether bacteria can survive to changing 
conditions and compete for the resources it needs to proliferate. Reversible phenotypic switching offers considerable 
advantages over conventional irreversible mutations. This chapter discusses the impact of generating population-level 
diversity on important clinical issues as resistance, virulence and persistence. It highlights that even though the growing 
interest and relevance of this phenomenon and its impact on bacterial ecology, the evolutionary origins and adaptive 
significance remain poorly understood. 
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1. Introduction 
In natural habitats, microorganisms are continuously challenged by external factors, being environmental adaptability 
essential for their survival. In fact, microorganisms can face many stressful conditions, such as starvation, temperature 
shocks, pH alterations, hypoxia or anoxia conditions, UV exposure, predation, antimicrobial agents challenge 
(antibiotics, biocides and disinfectants) and immune host defences [1]. The ability of microorganisms to change 
according to environmental fluctuations is termed as adaptive response. When environmental conditions alter, 
microorganisms trigger a set of complex regulatory networks that enable their survival. This microbial adaptation 
involves physiological, behavioural and genetic changes and can be achieved by different mechanisms, being 
phenotypic switching one of them.  
 Phenotypic switching was first described in Candida albicans over 20 years ago and later for other fungi as 
Crytococcus neoformans and other Candida species [2]. Lately, it was also been observed in bacteria as Pseudomonas 
aeruginosa, Staphylococcus aureus, Escherichia coli, Salmonella spp. and Neisseria spp. Phenotypic switching is being 
described for both pathogenic and nonpathogenic species, therefore there are undeniable reasons to examine thoroughly 
its role in microbial survival, pathogenicity and persistence.  
 Phenotypic switching or phase variation refers to a reversible switch between two phenotypic states, analogue to a 
mechanism ON/OFF. It normally occurs in a small fraction of the population at much higher rates than the frequency of 
spontaneous mutations. Phenotypic switching leads to two subpopulations with different gene expression: one sub-
population with altered expression of one or more phase variable genes; and other expressing the full genes profile [3]. 
An interesting feature of phenotypic switching is the referred mechanism ON/OFF, i.e., microorganisms can enjoy 
interchange of states. Although microorganisms exhibit one of the phenotypic states, they retain the possibility to switch 
again, if advantageous, when new environmental stimuli occur, or switch back to the previous phenotype state when the 
external stressor, that had provoked the switching, vanishes.   
 It has been long recognized that a genetically identical population (or isogenic population), even in a homogenous 
environment, can often have two or more phenotypes, being this feature termed as inherent phenotype heterogeneity or 
individuality. This microbial phenotype heterogeneity is a non-genetic variation, i.e. that does not involve changes in 
the genome, and it can be due to “noise”, i.e., variations result of the stochasticity of chemical reactions, at DNA level, 
such as random alterations in the rates of protein synthesis and degradation [4, 5]. Inherent phenotype diversity into a 
genetically identical population becomes evident by heterogeneous responses to stress [6], being this fundamental to 
microbial fitness and development. Despite phenotypic switching can be, in part, a random event (stochastic switching), 
several reports demonstrated that it can be modulated by external factors (responsive switching) [3, 7]. The microbial 
heterogeneity produced by phenotypic switching generates phenotype variants that are “fitter”, since this sub-population 
is better adapted to new environment than the other members of the population [8]. However, the fraction of the 
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population that preserves its phenotype unaltered ensures the ability of the population to overcome future and new 
adverse conditions that may occur. According to the ecological model “insurance hypothesis”, more biodiversity 
ensures ecosystems to maintain or enhance their functioning against environmental fluctuations [9]. Several reports 
about microbial diversity have been supporting this theory [10-12]. 
 Antigenic variation, in part, resembles phenotypic switching because it is also a heritable and reversible mode of 
switch between two phenotypes. However, antigenic variation involves alternating expression of a set of conserved 
moieties that are antigenically distinct within an isogenic population [13]. Phenotypic switching can lead to antigenic 
variation, since, for instances, it can affect the expression of outer lipopolysaccharides (LPS), pili and flagella [14, 15]. 
Phenotypic switching and antigenic variation can be a mixed strategy adopted by microorganism to face hostile habitats. 
 This chapter presents a review about phenotypic switching and its impact on bacteria fitness and persistence, as well 
as its significance on clinical context. Insights about phenotypic switching may provide valuable inputs into the 
dynamic of bacterial life. 
2. Colony morphology variants: the macroscopic feature of phenotypic switching 
The main consequence of phenotypic switching is the generation of heterogeneous and dynamic populations that can 
overcome stressful challenges. The most visible feature of phenotypic switching is colony morphology variation, 
termed as “dissociative behavior”, firstly described in 1964 by Zierdt et. al  [16]. Altered colony appearance were 
demonstrated for several bacteria as Burkholderia pseudomallei [17], Streptococcus pneumonia [18], Pseudomonas 
aeruginosa [19], Enterococcus faecalis [20] and Haemophilus influenzae [21]. Any modification in colony morphology, 
such as color, opacity and texture may be a sign of altered expression of one or more bacterial traits.  
Isolation and microbial identification through colony morphology are still methods of first line used by several 
laboratories and hospitals. The correlation between bacterial features and colony morphologies is just about unknown, 
however extremely important. Through colonies macroscopic visualization it may be possible to predict about which 
bacterial traits were probably altered and its relationship with external factors. Furthermore, the inspection of colonies 
will also help to establish relationships between colony morphology changes, virulence, antimicrobial resistance and 
persistence, which will be extremely useful on the design of biotechnological and therapeutic approaches. 
 Several colony mophotypes have been identified and described for several bacteria, being the best studied the small 
colony variants (SCV) [22, 23], the rugose small colony variants (RSCV) [24], and the mucoid morphotypes [25, 26]. 
Some of these morphotypes are associated with antimicrobial resistance, altered metabolism and reduced 
immunogenicity, contributing thus to increased bacterial pathogenicity and persistence. SCV have been implicated in 
persistent and recurrent human infections, such as cystic fibrosis (CF) [27] and device-related infections [28]. Deziel et 
al. [29] have characterized these variants as hyperpiliated and with increased ability to form biofilms in comparison 
with the fast growing wild morphotypes. Haussler et al. [19] have reported that, beyond hyperpiliated, SCV showed 
increased twitching motility, increased fitness under stationary growth and autoaggregative traits. Other features as 
auxotrophy [30], reduced respiration [31], resistance to aminoglycoside antibiotic [32] and ability to revert to normal 
morphotype [19], not always but often, have been also described. So far, the majority of studies concerning SCV are 
available for P. aeruginosa and S. aureus. The largest number of these laboratory-derived morphotypes may result from 
mutations. D´Argenio et al [33] have showed that a mutation in wspF of P. aeruginosa results in the arising of 
autoaggregative SCV with defects in swimming, twitching and swarming abilities. Drenkard and Ausubel [34] have 
reported the emergence of RSCV, a sub-group of SCV, after P. aeruginosa PA14 has been subjected to an antibiotic 
treatment with kanamycin. RSCV showed to be hyperadherent and possibly negatively controlled by the two-
component system response regulator homolog PvrR. RSCV are the unique variant of SCV described so far. However, 
recent work has identified several other subsets of SCV that are not mentioned in literature [35, 36]. Therefore, SCV 
may encompass a large number of variants possibly with important differences between each other in terms of virulence 
and resistance [36].  
 Besides SCV, particular attention has been also addressed to the mucoid phenotype. Mucoidy is associated to the 
overproduction of exopolysaccharides (EPS) and considered as a strongest virulence factor. P. aeruginosa mucoid 
variants overproduce alginate, a linear copolymer of 1,4-β-linked mannuronic acid and its epimer guluronic acid. 
Alginate has being ascribed as a significant virulent factor with various functions in the context of the pathogenesis of 
respiratory infections as in CF disease [26]. P. aeruginosa mucoid phenotype is closely associated with chronic 
infection and destruction of the lungs of patients with CF. During respiratory infection, P. aeruginosa converts from 
non-mucoid form (lower producer of alginate) to mucoid form (higher producer of alginate), being normally mutation in 
mucA responsible of this conversion [37]. The overproduction of EPS protects bacteria from host defences and 
antibiotic therapy extending the infection for a long time. 
 Apart from SCV and mucoid morphotype, other morphologies are underestimated, devaluated and poorly studied, 
being unknown their role and impact on diversity and dynamic of bacterial populations. In fact, there are several other 
morphologies that arise, for instance, after exposure to antimicrobial stress ensuring the bacterial response. As 
mentioned previously, stress response genes are triggered whenever bacteria need to adapt to adverse conditions. The 
rpoS and bolA genes are examples of those genes. RpoS, an alternative sigma factor of RNA polymerase, is the master 
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regulator of general stress response in E. coli and other proteobacteria. Its expression is susceptible to environmental 
alterations and is under strict control at transcriptional and post-transcriptional levels [38, 39]. The effect of rpoS on 
bacterial virulence is variable differing between species [40]. bolA is a morphogene of E. coli that causes round shape of 
bacteria and increased ability to form biofilms. bolA expression is induced by several types of stress factors such as heat 
shock, acid environment, oxidative and osmotic stress and carbon starvation [41, 42]. Colony morphologies of E. coli 
K12 with bolA and rpoS mutations were observed (Fig. 1) to assess the impact of these genes on phenotype 
determination. 
 
 
(a) 
 
(b) (c) 
Fig.1 Colony morphology of E. coli (a) wild-type, (b) rpoS mutant and (c) bolA mutant on TSA plates. Black bars = 1 mm. 
 
The observation of Fig. 1 allowed to denote important differences between the colony morphologies adopted by the 
three E. coli strains, confirming the influence of bolA and rpoS on morphology variation. rpoS mutation reduced 
significantly the size of the colonies and altered its texture. bolA mutation also altered the colony texture and induce a 
well defined circular shape. The impact of these genes on colony morphology when E. coli is exposed to antimicrobial 
stressors is under investigation. Preliminary results revealed that colony morphology variation between stressed mutants 
is even greater than that observed with un-stressed E.coli. 
3. Biofilm phenotypic switching 
In “real world” environments, bacteria prevail in organized communities entrapped in an exopolysaccharide matrix 
called biofilm [43]. Biofilm formation is an efficient microbial strategy to persist in unfavourable environments. 
Bacteria in biofilm benefit from various advantages over their planktonic counterparts, such as increased antimicrobial 
resistance and protection against predation, dehydration and phagocytose [44]. Biofilms are initiated when free-living 
bacteria attach irreversibly to an abiotic or biotic surface. Furthermore, bacteria grow and divide forming a mature 
biofilm. During biofilm growth, bacteria adopt a biofilm-specific phenotype, radically different from that expressed in 
the corresponding planktonic cells.  
 To switch from planktonic to biofilm mode of growth, bacteria undergo a number of complex physiological, 
metabolic and phenotypic differentiations [45]. Biofilm-growing bacteria undertake specific changes in physiological 
and protein regulation, especially those related with proteins involved in resistance to oxidative damage, 
exopolysaccharide production, phospholipids synthesis and membrane transport [46]. This switch to biofilm-specific 
phenotype can trigger mechanisms responsible for antimicrobial resistance, enhanced virulence and persistence [47]. 
Some genes are differentially expressed in biofilm mode of growth, such as those implicated in pili and flagella 
synthesis, signifying that these elements are no longer required in mature biofilms [45, 46].  
 Within biofilms there are a range of microniches with specific biological activities that may somewhat translate the 
well-known biofilm heterogeneity. This biofilm diversity can generate several distinct colony morphologies because of 
those sub-populations. The morphotypes resulting from clinical-isolated and wild-type P. aeruginosa biofilms (Fig 2) 
emphasize the diversity of colony morphologies presented by biofilm-growing cells.  
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Fig. 2 Colony morphology diversity of 24-hour-old P. aeruginosa biofilms formed on TSB by ATCC10145 strain (top row) and by 
clinical isolate (down row).  Black bars = 1 mm, white bars = 0,5 mm 
 
 P. aeruginosa ATCC10145 biofilms generated three different colony morphotypes (Fig 2). This population 
variability can be the evidence of the well-described heterogeneity within biofilms imposed by chemical gradients, such 
as nutrients, oxygen and metabolic waste products. As Stewart and Franklin [48] reported, in a mature biofilm, at least 
three distinct physiological states can be anticipated: cells near the biofilm-bulk-fluid or in the more superficial layer, 
presenting similarities with planktonic cells; cells in the middle zone; and cells in the deeper zone. The three colony 
variants showed on the top row of Fig. 2 can be the macroscopic expression of the phenotypes of these different zones. 
In fact, it was verified that the colony variant represented by Fig 2a is similar to the morphotype commonly observed 
with P. aeruginosa planktonic cultures [35].  
 The biofilms formed by the isolated P. aeruginosa strain gave rise to a morphotype diversity almost 4-fold higher 
than the observed with P. aeruginosa wild-type (only few morphotypes are displayed in Fig. 2). The clinical isolate 
demonstrated to have a huge ability to generate new colony morphotypes, especially, in stressful conditions. 
Furthermore, the features of the colony variants were clearly different from those of the reference strain -  ATCC10145 
- (Fig 2 d, e and f), probably due to their different genetic backgrounds [35]. It was evident the prevalence of SCV 
resulting from the clinical-isolated P. aeruginosa biofilms. This occurrence has been associated with a better response 
of bacteria to environmental challenges. For instance, the antimicrobial resistance often exhibited by biofilms has been, 
in part, attributed to the biofilm-specific phenotype, where SCV play a key role [18, 19, 22, 34]. However, it was 
demonstrated that the SCV phenotype may not be exclusive of biofilms [49]. Therefore, it remains unclear the existence 
or not of a colony morphology that could represent exclusively a biofilm-specific phenotype. 
 Biofilm-colony diversity is also influenced by the stage of biofilm development [46]. Boles et. al [10] showed that 
biofilms over time were differently composed by “mini” and wrinkled colony variants. The different proportion of each 
variant during biofilm formation and, especially, after biofilm exposure to environmental stresses, suggests that colony 
variants have specialized functions in biofilm establishment and in its survival strategy that ensure the increased biofilm 
tolerance to stressors [12, 50, 51].  
 The phenotypic heterogeneity within biofilms is considered one of major reasons of biofilm recalcitrance. Many 
different colony morphologies can be isolated from biological samples from chronic infections such as CF sputum, in 
which bacteria reside in biofilms [52]. However, the study regarding biofilm phenotypic switching is recent and several 
questions still remain to be answered. Despite the progress obtained in this topic, several issues related, for instance, 
with polymicrobial biofilms are still an unexplored research area. In nature, biofilms are rarely composed by unique 
specie. In fact, biofilms are consortia of several species including bacteria, fungi and virus, being thus essential the 
characterization and study of the relationships and interplays between species and their adaptive responses.  
 From the evolutionary standpoint, biofilms represent an undeniable advantage to persist in hostile environments. The 
relationship between biofilms and biofilm-specific colony morphotypes is unclear. Hence, it is necessary to elucidate 
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the role of colony variants of the biofilm-associated bacteria for understanding hot issues related with the biofilm mode 
of growth, like chronic infections, ecological processes and antimicrobial resistance.  
4. Virulent phenotypic variants 
Phenotypic switching is traditionally considered as a mechanism to evade host immune defences because it has been 
associated with many human pathogens. In fact, phenotypic switching assists bacteria to escape to innate and acquired 
immune mechanisms during colonization and infection, by affecting the host-pathogen interactions [3]. The basis of this 
process is that the subpopulations generated by phenotypic switching exhibit different sets of antigens and the immune 
system only react against those antigens that recognize. Therefore, colony variants become a problem when the host 
immune system does not operate effectively in their elimination [53]. This concept of enhanced virulence is supported 
by antigenic variation principle. However, if bacteria switch OFF the expression of an antigen, it may means that they 
lose the biological function associated with this antigen. Hence, functional redundancy is required for bacteria not 
mislay the biological function of that antigen. The frequency by which antigenic variation occurs is unclear mainly due 
to limited number of studies about it [3]. 
 In a study related to systemic infection in animal model, Kim et. al [54] have reported that opaque colony variants of 
Streptococcus pneumoniae exhibited higher virulence than translucent variants in each three strains examined. This 
difference can be explained by the 6-fold amount of capsular polysaccharide and 2-fold less teichoic acid synthesis of 
opaque variants. Similar trends were observed for Helicobacter pylori [55], Salmonella enterica [56] and Pseudomonas 
fluorescens [7]. So far, it is unclear what prompts bacteria to switch despite some authors proposed that the host 
environment may exert bacterial selection pressure [57].  
 For some chronic infections, the switch of colony morphotype is one of the crucial stages. As previously mentioned, 
in CF lungs, P. aeruginosa colony morphology undergoes a conversion to mucoid form by overproduction of alginate. 
Alginate is thought to have a protective function in a relatively harsh environment in which the bacteria are continually 
subjected to oxidative stress and attacked by the immune system. Therefore, in the mucoid phenotype, bacteria become 
more difficult to eradicate [58], being able to survive for years with the most surface and virulence factors 
downregulated [59, 60]. The frustrated immunologic response, characterized by an influx of neutrophils to the lung, 
causes tissue damage over time, due to the indiscriminate release of reactive oxygen species during oxidative burst, 
resulting in significant morbidity and mortality [61, 62]. The conversion to mucoidy, together with biofilm formation, 
are both important virulence aspects of CF pathogenesis, however the relationship between them is at the present 
unclear. 
 Colony variants as SCV exhibit several particular characteristics that make them excellent opponents of the host 
defence agents. Besides the features abovementioned, SCV have better ability to develop biofilms and to adhere to 
epithelia, being sometimes more cytotoxic to macrophages [19, 34, 50]. The SCV emergence, for instance in CF lungs, 
may be caused by host environment selective pressure, namely by the presence of antibiotics, the action of host immune 
agents or by the synergy of the two factors [57]. The hyper-biofilm ability of any colony variant is an important 
virulence factor. Biofilms demonstrated reduced activation of the complement system and, as biofilm-growing bacteria 
are entrapped within the EPS matrix, they are less susceptible to phagocytosis. In some cases, biofilms are resistant 
even to humoral immune response [61].  
5. Phenotypic variants resistant to antimicrobial agents 
Phenotypic switching does not only help bacteria to evade the host immune defences, but also have impact on other 
biological features. As aforesaid, for some microorganisms the relationship between phenotypic switching and 
microbial virulence are already established, however, it is urgent to re-examine phenotypic switching as a phenomenon 
with impact on other biological processes, as antimicrobial resistance.  
 Nowadays, disinfection procedures and antimicrobial therapeutic treatments are usually noneffective. It is well-
known that the use and over-use of antimicrobial agents have amplified the emergence of resistant bacteria [63]. 
Antimicrobial research has been focused essentially on antibiotics because the huge impact of recalcitrant infections 
caused by antibiotic-resistant strains on humans. The several resistance mechanisms adopted by bacteria include 
modification of the target site, degradation of the antibiotic molecule and reduction of effective intracellular antibiotic 
concentration through decreased permeability and efflux pumps [64, 65]. Antibiotic resistance is generally associated 
with fitness costs for bacteria, however, Massey et al. [66] demonstrated a mechanism that contradicts those bacterial 
costs, the arising of SCV. According to the latter authors, S. aureus exposure to gentamicin both in vitro and in vivo 
resulted in the emergence of SCV. In the absence of antibiotic pressure, the SCV reverts to normal phenotype, avoiding 
thus the disadvantageous fitness costs associated with irreversible resistance mutation. The typical characteristics of 
SCV, such as small size, slow growth rate, pigmentation and higher resistance to antibiotics and cell-wall inhibitors, are 
due to defects in electron transport chain [28, 67] caused by genetic mutations as menD, hemB and ctaA [28].  
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 The majority of SCV are isolated from biofilms either under stresse or not. Actually, biofilms have been increasingly 
recognized as an important issue in human disease due to their notoriously resistance, achieving 10 to 1000 fold higher 
tolerance to antimicrobial agents than corresponding planktonic bacteria. This resistance has multifactorial nature, i.e., 
results from the combination of several mechanisms including restricted penetration of antimicrobials through the 
exopolysacharide matrix, slow growth of bacteria within biofilms caused by nutrient and oxygen restriction and 
accumulated metabolic wastes and quorum-sensing molecules that leads to biofilm recalcitrance [61]. 
 In the field of antimicrobial resistance, research related with bacterial resistance to disinfectants and biocides has 
been undervalued. Clinical settings are a particular environment that shelters a lot of pathogens mainly in abiotic 
environmental surfaces, air and water. Surface disinfection is one of the most important clinical procedures that can 
effectively reduce the number of healthcare-associated infections [68]. This kind of infections is somewhat caused by 
the spreading of pathogens through surfaces surrounding patients and healthcare professionals. Unfortunately, 
disinfection procedures are not always performed in an accurate way. In fact, inadequate agents and doses are 
frequently used which may contribute to the development of resistant bacteria [63]. Although there is much concern 
regarding the risks of antibiotic resistance, there is a lack of studies evaluating the performance of disinfectants and 
biocides against planktonic and sessile bacteria and the tolerance induced by the use of those agents. Studies that relate 
the phenotypic switching and the development of tolerance by biofilm-growing bacteria towards disinfectants and 
biocides are even less. Recent work showed that disinfectant exposure altered biofilm population diversity [35, 36]. In 
order to attempt comprehending the relationship between disinfectant stress and biofilm diversity, 24-hour-old biofilms 
were exposed to several different disinfectants of clinical use and bacterial colony diversity was assessed. Data 
demonstrated that biofilm diversity was altered for all disinfectants tested but with different proportions of colony 
variants. Given the variety of phenotypes observed in the unstressed and stressed biofilms, it is likely that those variants 
an important play a role in the biofilm adaptive response and community survival.  
6. Phenotypic persisters  
One the most remarkable feature of bacteria is their ability to persist after severe stressful situations. When an isogenic 
population is exposed to lethal conditions, such as a bactericidal dose, most of the cells are killed. However, a small 
fraction of the bacterial population, called as persister cells, can survive. Persisters are not resistant cells and do not 
have genetically acquired antimicrobial resistance. They are dormant cells, i.e., they remain metabolically inactive in 
stressful conditions, in a “non-dividing state” [69]. After removal of the lethal conditions, they can resort to normal 
growth rates and generate a new population that is equally susceptible. It has been proposed that the persister cells 
ability to revert to original population is a sign of phenotypic switching. 
 Despite the discovery of persister cells over 60 years by Bigger et. al [70], the knowledge about them is still too 
young mainly due to technical difficulties of working with a such small amount of cells, normally range from 10-6 to 10-
4 of the entire population. The fact of such important phenotype be expressed only temporarily may also account for the 
lack of studies related with persister cells. Therefore, the mechanisms underlying bacterial persistence remain a puzzle 
and the knowledge about the traits of colonies formed by persisters is unknown.  
 Currently, there are in literature various hypotheses explaining persisters formation. The most important is related to 
the assumption that persistence is a phenotypic state [71]. In previous works developed by Lewis [72, 73], it is 
suggested that stochastic switching or “noise” in toxin-antitoxin balance could be responsible for the switch to persister 
state. Prokaryotes have in its genome and plasmids genetic elements designed as toxin-antitoxin modules (TA). TA are 
generally two genes operons: one  encoding a stable toxin that inhibits some important cellular functions; and  another 
one encoding  an unstable antitoxin that neutralizes the toxin and also acts as an autoregulator of expression [74, 75]. 
The role of TA in programmed cell death is controversy. The most recent hypothesis proposed that toxins target 
essential biological processes such as DNA replication and protein translation promoting by this way, bacteriostasis. 
Some studies have been proposed that stochastic fluctuations in TA ratios can lead to transient growth states and 
antibiotic resistance. Thus, evolution seems to have favoured stochastic switching rather than responsive switching that, 
in some stressful situations, may not occur convicting the whole population to death [76]. In addition, if the population 
were diverse or “insure”, the probability of bacteria survive further increase with the diversity degree.  
 Persisters have been greatly associated with antibiotic resistance because antibiotics failure to kill this residual 
fraction of cells. In general, non-growing or slow-growing cells are not, or at least are less, susceptible to antibiotic 
action. Thus, persisters can prevent clearance of bacteria, especially when bacteria are within biofilms. The occurrence 
of persisters cells within a biofilm population has been pointed out as a mechanism of biofilm resistance towards 
antimicrobials In fact, the enhanced antimicrobial resistance of biofilms has been associated not only to SCV phenotype 
but also to the presence of the persister phenotype [77, 78]. Singh et. al [22] reported that biofilms harbour a increased 
number of  persisters cells when compared with planktonic counterparts and those persisters were more difficult to 
eradicate due to the exopolysaccharide matrix protection. So far, only the operon hipAB is known to affect the 
development of persisters [79].  
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7. Phenotype plasticity: mechanisms of phenotypic switching 
Despite the increasing number of studies about phenotypic switching, the molecular mechanisms underlying this 
phenomenon are poorly understood. In some bacterial species, specific phenotypic switching mechanisms with genetic 
basis seem to be more prevalent and, in other species, mechanisms with no genetic basis, as epigenetic regulation, have 
been identified [6, 13]. 
 Bacteria can respond to environmental stresses by modulating gene expression through sigma factors, proteolysis and 
other mechanisms [80]. Nevertheless, bacteria can experience many, in number and variety, unpredictable stimuli that 
gene regulation system cannot foresee. Thus, in absence of any pre-determined mechanism, the classical genetic view of 
a sensor-effect regulatory system, as bacteria strategy to respond to environmental stresses, seems to be inadequate [14, 
80].  In addition, classical genetics does not explain the phenotype heterogeneity into an isogenic population.  
 The best approach to bacteria achieve adaptation by genetic strategies is through mutations and/or horizontal gene 
transfer. However, adaptation through spontaneous mutations is difficult, although not impossible, since these mutations 
occur at very low frequency. Increased mutation rates, known as hypermutability, could be an efficient approach to 
acquired genetic diversity [80, 81]. Hypermutability could be beneficial or adverse since bacteria, in the long run, will 
face a high risk of accumulation of unwanted and deleterious mutations or antagonistic pleiotropy or both. The 
mechanisms of hypermutability have exhaustively reviewed by Jayaraman [82].  
 As previously mentioned, phenotypic switching is an efficient strategy of generate a diverse population, able to 
survive in hostile environments, by high frequency and reversible switch (ON/OFF) of the expression of one or more 
genes. This class of genes that are expressed in a phase variable manner is called as “phase variable genes” or, more 
often, as “contingency genes”. Contingency genes are genomic regions able to reversibly alter between two forms at 
high frequency. Most of the contingency genes are involved in the synthesis or modification of surface-associated 
structures and enzymes. Thus, mutations in those genes cause modifications in protein regulation and in bacterial 
phenotype [13-15], being the majority of them located in coding sequence of virulent factors. The reversible switch of 
phenotypes has been explained by a mechanism called “slipped strand mispairing” (SSM) [8, 83]. SSM has been 
identified in several bacterial species [83]. This process can occur during DNA synthesis, as replication, repair and 
recombination. Short sequence repeats (SSRs), homopolymeric tracts (e.g TTTTTTTTTTTTT) or multimeric repeats 
(e.g. TAATAATAATAATAATAA), associated with SSM regulate gene expression at the translational or 
transcriptional level. SSR associated with a single locus, located in the promoter region or in coding region, can then 
alter gene expression and lead to phenotypic switching [80, 81, 83]. SSM occurs when a repeat sequence pair out of the 
original complementary part of the opposing strand (template), but with some other area containing the complementary 
base. A loop is formed in the template or nascent DNA, as the mismatching occurs, if it is a forward or a backward 
slipping, resulting in a contraction or expansion of the length of repeats, respectively. The altered DNA repeat length 
can result in altered translation of an encoded protein or different transcriptional activity of a determined gene.   
 SSM is the most common mechanism underlying phenotypic switching, but not the only one. Other mechanisms, 
including homologous recombination, site specific recombination, transposon insertion/excision and differential DNA 
methylation, may cause phenotypic switching [80]. In this review, only a brief description of the features of those 
mechanisms will be presented. Additional information can be obtained in literature [8, 81, 84]. 
 The switch of phenotype determines the presence or absence of several surface structures. At simplest outlook, 
homologous recombination is the breaking out of two DNA molecules at a single point and the crossing between each 
other. The result is two DNA molecules, called recombinant DNA, with a part of parental molecule. This mechanism 
requires some homology between sequences to happen. An example of phenotypic switching by homologous 
recombination is the transcriptionally interchange between active gene pilE and silent of pilS gene. In contrast, site-
specific recombination requires little or no homology between molecules since it works with specific sequences. In site-
specific recombination occurs the inversion (flipping) of short DNA segments encompassing the promoter of a phase 
variable gene which is recognized by the corresponding recombinase. The activity of the recombinase may be 
influenced by environmental factors. The switch of phenotypes occurs when the inversion changes the transcription or 
translation of a gene. In one orientation the gene is expressed (ON state) and in the other not (OFF state) [8, 80, 84]. 
The best characterized example of site-specific recombination is the phase variable expression of E. coli type 1 fimbria 
expressed by the fimA gene. Phenotypic switching can be the result of insertion and excision of transposable elements. 
Transposons are mobile genetic elements able to move (transpose) from one DNA site to another. Some transposons 
target site seems to be more or less random and others seem have target specificity. For instance, the insertion of 
IS2561transposon causes phase variable expression of the cca gene in S. epidermidis [13]. DNA methylation is a 
pseudo-genetic mechanism because is a process of regulation of gene expression but, as it acts directly on DNA, it can 
be considered on the set of genetic mechanisms. Phenotypic switching by this mechanism results from differential 
methylation patterns carried out by deoxyadenosine methyolase (Dam) which methylates 5’-GATC sequences. The 
competition between Dam and transcriptional regulatory proteins for DNA binding sites cause changes in methylation 
and, consequently, they can be used by bacteria to regulate the expression of certain genes in a phase-variable manner. 
The type of the binding regulator determines the ON and OFF state [8, 83]. The phase variable expression of the E. coli 
pap pilin is a well-known example of the Dam-mediated phenotype variation. 
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 Phenotype variation can also be due to stochastic variation or “noise” at transcriptional and translational level [5, 6]. 
Although all population members have the same genome, noise can wrest differently the information in each individual 
cells. Some biological reactions are, in fact, inherently noisy because mainly the reduced number of participating 
molecules. For instance, transcription and translation are processes involving low-abundance molecules in comparison 
with protein-protein interactions [4, 5]. Noise with amplification, i.e., in the presence of positive feedback, can originate 
at population level the switch-like behaviour, resulting in two or more different sub-populations. This process is called 
bistability, if there are two stable genetic states, or multistationarity, if there are multiple stable genetic states [4]. 
However, not always noise can be translated in phenotype variation. In some cases, the biochemical network, in which 
the gene product is inserted compensates the fluctuations without alter the phenotype [5]. 
 Currently, there are still a lot of gaps about molecular mechanisms related with phenotypic switching. New 
experimental approaches to study the phase variable systems are being developed and promising data will soon arise.   
8. Concluding Remarks 
To successful colonized new environments or simply to survive to stressors, bacteria need to recur to evolution and 
diversification. Phenotypic switching provides a source of microbial diversity fundamental to bacterial fitness and 
development. Through phenotypic switching, bacteria have the potential to better survive in hostile environments due to 
the creation of several variants equipped to persist to stresses. In addition, bacteria have not the costs of an irreversible 
state, as mutations, allowing, if more advantageous, to revert to the previous phenotype. There are numerous phenotypic 
variants that have been recovered after in vitro stresses or even isolated from patients with different infections. This 
huge diversity is the evidence of the significance of phenotypic switching. 
 Phenotypic switching has been shown to influence bacterial virulence and also antimicrobial resistance. SCV are the 
best example of how phenotypic switching can alter the antimicrobial resistance profile and virulence ability. SCV has 
been isolated from several types of disease, as respiratory, urinary and device-related infections demonstrating their 
great adaptability in such different environments.  
 Biofilm development is an important strategy to bacterial survival. To form biofilms, bacteria have to switch to the 
biofilm-specific phenotype. The study of phenotypic switching in the scope of biofilms is still limited. It is essential 
understanding how phenotype conversion contributes to better form biofilms and the impact of this conversion on 
infectious disease, antimicrobial resistance and persistence. Biofilm studies are not simple because the multifaceted 
nature and adaptive plasticity exhibited by bacteria in response to external factors. Simulating real conditions with 
collection and clinical microbial specimens will be useful towards the understanding of the evolved concepts in 
biofilms.  
 The concept of on-off switching of phenotypic states is a quite simple view of a complex process. Phenotypic 
diversity can be mediated by specific genetic alterations or by epigenetic mechanisms. Hence, it has been difficult to 
demonstrate whether the mechanisms attributed to phenotypic switching in vitro are the same at play in vivo. The 
majority of experimental reports regarding phenotypic variation have studied new and constant environmental changes. 
However, in real situations changes occur instantaneously and are unlikely to remain constant over the time for the 
fixation of the mutations. It starts now to be evident some differences between in vitro and in vivo emergence of 
microbial colony variants. Because of this discrepancy between laboratory studies and real situations, the knowledge 
about phenotypic variation is delayed. Therefore, it is necessary to perform in vivo studies to test hypotheses raised by 
the in vitro experiences and to draw correlations between morphotypes generated in vitro and in vivo. 
 Apart from phenotypic switching, it is evident another important phenomenon, the bacterial individuality or inherent 
phenotypic variation. The cell-to-cell phenotypic variability within an isogenic population also provides a dynamic 
source of diversity. It has received attention from the scientific community due to their implications on the treatment of 
chronic infections. Inherent heterogeneity is often masked in experimental conventional, since they generally used data 
average population-level phenotypic responses from thousand or even millions of bacteria in a single sample. Bacterial 
individuality has been proposed to be owed to “genetic noise”, i.e., cell-to-cell fluctuation in gene expression. The 
development of diverse phenotypes independently of environmental factors is a relevant issue from the evolutionary and 
adaptation standpoints. 
 Taking into account all the information available so far, it is difficult to argue against the great importance of 
phenotypic switching. However, there is still a lack of knowledge about phenotypic varying systems. The understanding 
of the phenotypic switching processes and the response of the bacterial population to environmental stresses is 
fundamental to develop adequate disinfection protocols and therapeutic treatments. The knowledge of the determinants 
of phenotypic switching can be of greater significance to solve real problems, such as multi-antimicrobial resistance, to 
design therapeutic approaches and vaccine development for some clinical diseases. 
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